The latest announcement is out from Nanosonics Limited ( (AU:NAN) ).
Nanosonics Limited reported an 18% increase in revenue to $93.6 million for the half-year ending December 2024, with a notable 124% rise in profit before tax. The results reflect strong operational performance and market demand, positioning the company favorably in the infection prevention industry. Despite the growth, no dividends were distributed during this period, and there were no changes in control over entities.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, focusing on infection prevention solutions. The company is known for its innovative disinfection technology, particularly in the ultrasound market, and has a significant presence in various international markets through its subsidiaries.
YTD Price Performance: 22.99%
Average Trading Volume: 1,086
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $663M
For detailed information about NAN stock, go to TipRanks’ Stock Analysis page.